Intermittent oxygen therapy for chronic fatigue syndrome
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests a treatment called intermittent hypoxia-hyperoxia therapy (breathing air with lower then higher oxygen levels) to see if it can improve fatigue, pain, and quality of life in people with ME/CFS. The study focuses on women with mild or moderate ME/CFS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman, between 20 and 59 years old, and have a body mass index (BMI) between 18 and 30.
- You have a formal diagnosis of ME/CFS (chronic fatigue syndrome) that has lasted more than 6 months.
- You experience post-exertional malaise (symptoms get worse after activity).
- Your ME/CFS severity is mild or moderate (you can do some daily activities but need rest).
- You can attend study visits and follow the treatment schedule.
- You are willing to use effective contraception if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether breathing pure oxygen in a pressurized chamber can reduce fatigue and improve symptoms in people with mild-to-moderate chronic fatigue syndrome (ME/CFS). The therapy may help your body recover better by increasing oxygen supply to affected tissues.
This study tests whether brief periods of breathing air with lower oxygen levels can help people with different stages of multiple sclerosis (MS). It aims to see if this approach is safe and maybe beneficial.
This study tests whether breathing lower-oxygen air in short breaks changes how the brain and body respond. It is only for medically stable, healthy adults with specific safety screening.
This trial studies how people with ME/CFS respond to an exercise test. It may help researchers understand what kind of exercise response is typical and how it relates to symptoms.
This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.
This trial tests whether brief sessions of breathing lower-oxygen air can improve sleep in people with primary insomnia. It may offer a drug-free approach to better sleep.
Hear when a new Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.